Thiamine prevents obesity and obesity-associated metabolic disorders in OLETF rats

T Tanaka, T Kono, F Terasaki, K Yasui… - Journal of nutritional …, 2010 - jstage.jst.go.jp
We previously found that thiamine mitigates metabolic disorders in spontaneously
hypertensive rats, harboring defects in glucose and fatty acid metabolism. Mutation of …

Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet

X Gao, X Liu, J Xu, C Xue, Y Xue, Y Wang - Journal of bioscience and …, 2014 - Elsevier
Trimethylamine N-oxide (TMAO) is an oxidation product of trimethylamine (TMA) and is
present in many aquatic foods. Here, we investigated the effects of TMAO on glucose …

[HTML][HTML] Effect of chronic western diets on non-alcoholic fatty liver of male mice modifying the PPAR-γ pathway via miR-27b-5p regulation

J Zhang, CA Powell, MK Kay, R Sonkar… - International journal of …, 2021 - mdpi.com
Western diets contribute to metabolic diseases. However, the effects of various diets and
epigenetic mechanisms are mostly unknown. Here, six week-old C57BL/6J male and female …

Perindopril prevents development of obesity and hypertension in middle aged diet-induced obese rat models of metabolic syndrome

K Connolly, R Batacan Jr, D Jackson, R Vella… - Life Sciences, 2023 - Elsevier
Aims The therapeutic properties of anti-hypertensive medications that extend beyond blood
pressure lowering have started to become important clinical targets in recent years. This …

[HTML][HTML] Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese …

CM Sampson, AL Dimet, H Neelakantan… - Scientific reports, 2021 - nature.com
Obesity is a large and growing global health problem with few effective therapies. The
present study investigated metabolic and physiological benefits of nicotinamide N …

Targeting mineralocorticoid receptors in diet-induced hepatic steatosis and insulin resistance

J Habibi, D Chen, JL Hulse… - American Journal …, 2022 - journals.physiology.org
Mineralocorticoid receptor (MR) activation plays an important role in hepatic insulin
resistance. However, the precise mechanisms by which MR activation promotes hepatic …

Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis

J Monsénégo, A Mansouri, M Akkaoui, V Lenoir… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: Despite major public health concern, therapy for non-alcoholic fatty
liver, the liver manifestation of the metabolic syndrome often associated with insulin …

Oral metformin treatment counteracts adipoinsular axis dysfunction in hypothalamic obese rats

D Castrogiovanni, L Ongaro, G Zuburía… - International …, 2015 - Wiley Online Library
Rats neonatally treated with monosodium L‐glutamate (MSG) are deeply dysfunctional in
adulthood. We explored the effect of an oral low dose of metformin treatment in male MSG …

Quinizarin suppresses the differentiation of adipocytes and lipogenesis in vitro and in vivo via downregulation of C/EBP-beta/SREBP pathway

J Ree, JI Kim, CW Lee, J Lee, HJ Kim, SC Kim… - Life Sciences, 2021 - Elsevier
Aims Potential anti-obesity effects of quinizarin, a plant anthraquinone, were investigated
using 3 T3-L1 preadipocyte cells and high-fat diet (HD)-induced obese mice. Main method …

[HTML][HTML] Metformin reduces macrophage HIF1α-dependent proinflammatory signaling to restore brown adipocyte function in vitro

N Pescador, V Francisco, P Vázquez, EM Esquinas… - Redox Biology, 2021 - Elsevier
Therapeutic potential of metformin in obese/diabetic patients has been associated to its
ability to combat insulin resistance. However, it remains largely unknown the signaling …